These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10069538)

  • 21. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
    Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
    Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The postantifungal effect (PAFE) of itraconazole, in comparison with those of miconazole and fluconazole, on Candida Species.
    Uchida K; Abe S; Yamaguchi H
    Microbiol Immunol; 2006; 50(9):679-85. PubMed ID: 16985289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect.
    Gunderson SM; Hoffman H; Ernst EJ; Pfaller MA; Klepser ME
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2887-90. PubMed ID: 10991881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study.
    Mansourian A; Boojarpour N; Ashnagar S; Momen Beitollahi J; Shamshiri AR
    J Mycol Med; 2014 Dec; 24(4):e163-8. PubMed ID: 25442923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inhibitory effects of carvacrol, nystatin, and their combination on oral candidiasis isolates.
    Balef SSH; Hosseini SS; Asgari N; Sohrabi A; Mortazavi N
    BMC Res Notes; 2024 Apr; 17(1):104. PubMed ID: 38605312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-antifungal effect and adhesion to buccal epithelial cells of oral Candida dubliniensis isolates subsequent to limited exposure to amphotericin B, ketoconazole and fluconazole.
    Ellepola AN; Chandy R; Khan ZU
    J Investig Clin Dent; 2015 Aug; 6(3):186-92. PubMed ID: 24850753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fungal profile and antifungal susceptibility pattern in patients with oral candidiasis.
    Sav H; Altinbas R; Dursun ZB
    Infez Med; 2020 Sep; 28(3):392-396. PubMed ID: 32920575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the post-antifungal effect (PAFE) of amphotericin B and nystatin against 30 zygomycetes using two different media.
    Vitale RG; Meis JF; Mouton JW; Verweij PE
    J Antimicrob Chemother; 2003 Jul; 52(1):65-70. PubMed ID: 12775672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
    Khan F; Baqai R
    J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis.
    Gil-Alonso S; Jauregizar N; Eraso E; Quindós G
    PLoS One; 2015; 10(7):e0132730. PubMed ID: 26168269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exposure to subtherapeutic concentrations of polyene antifungals suppresses the adherence of Candida species to denture acrylic.
    Egusa H; Ellepola AN; Nikawa H; Hamada T; Samaranayake LP
    Chemotherapy; 2000; 46(4):267-74. PubMed ID: 10859432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of two different growth media on the postantifungal effect induced by polyenes on Candida species.
    Shu M; Ellepola AN; Samaranayake LP
    J Clin Microbiol; 2001 Jul; 39(7):2732-5. PubMed ID: 11427609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postantifungal effect of anidulafungin against Candida albicans, Candida dubliniensis, Candida africana, Candida parapsilosis, Candida metapsilosis and Candida orthopsilosis.
    Gil-Alonso S; Quindós G; Eraso E; Jauregizar N
    Rev Esp Quimioter; 2019 Apr; 32(2):183-188. PubMed ID: 30847462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and antifungal susceptibility of yeasts obtained from the oral cavity of elderly individuals.
    de Resende MA; de Sousa LV; de Oliveira RC; Koga-Ito CY; Lyon JP
    Mycopathologia; 2006 Jul; 162(1):39-44. PubMed ID: 16830190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of antifungal polyenes on the adhesion of Candida albicans and Candida glabrata to human epithelial cells in vitro.
    Dorocka-Bobkowska B; Konopka K; Düzgüneş N
    Arch Oral Biol; 2003 Dec; 48(12):805-14. PubMed ID: 14596870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of antifungal activity of standardized extract of Salvia rhytidea Benth. (Lamiaceae) against various Candida isolates.
    Salari S; Bakhshi T; Sharififar F; Naseri A; Ghasemi Nejad Almani P
    J Mycol Med; 2016 Dec; 26(4):323-330. PubMed ID: 27499461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata.
    Samaranayake YH; Yau JY; Thein ZM; Jayatilake JA; Yeung KW; Samaranayake LP
    Med Mycol; 2010 Aug; 48(5):725-34. PubMed ID: 20092419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brief exposure to antimycotics reduces the extracellular phospholipase activity of Candida albicans and Candida tropicalis.
    Anil S; Samaranayake LP
    Chemotherapy; 2003 Sep; 49(5):243-7. PubMed ID: 14504435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic anticandidal activity of menthol in combination with itraconazole and nystatin against clinical Candida glabrata and Candida krusei isolates.
    Sharifzadeh A; Khosravi AR; Shokri H; Tari PS
    Microb Pathog; 2017 Jun; 107():390-396. PubMed ID: 28431915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.